Literature DB >> 9255106

Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells.

R Lemaire1, G Huet, F Zerimech, G Grard, C Fontaine, B Duquesnoy, R M Flipo.   

Abstract

We have investigated the potent influence of some cytokines, tumour necrosis factor-alpha (TNF-alpha), platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF) and interferon-gamma (IFN-gamma), on the secretion of cysteine proteinases (cathepsins B and L) by cultured synovial fibroblast-like cells from patients with rheumatoid arthritis (RA). After treatment of synovial fibroblast-like cells with cytokines, culture media were evaluated for cathepsins B and L by enzyme immunoassays, and for cathepsin B and L activities using the enzymatic substrates. Z-Phe-Arg-AMC and Z-Arg-Arg-AMC, and specific inhibitors. Treatment of synovial fibroblast-like cells with TNF-alpha or PDGF resulted in a marked increase in cathepsin B secretion. Moreover, after prolonged PDGF treatment, the amount of secreted cathepsin B returned to the low control level. In contrast, bFGF led to increased cathepsin L secretion. IFN-gamma induced both cathepsin B and L secretion. Our results show that cytokines induce a selective secretion of cathepsins B and L by synovial fibroblast-like cells. This selective effect of cytokines on the secretion of cysteine proteinases suggests that synovial fibroblast-like cell-mediated articular degradation is a highly regulated process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255106     DOI: 10.1093/rheumatology/36.7.735

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  26 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

2.  Single Cell Chemical Cytometry of Akt Activity in Rheumatoid Arthritis and Normal Fibroblast-like Synoviocytes in Response to Tumor Necrosis Factor α.

Authors:  Emilie R Mainz; D Stephen Serafin; Tuong T Nguyen; Teresa K Tarrant; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Chem       Date:  2016-07-20       Impact factor: 6.986

3.  Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.

Authors:  Urska Repnik; Amanda E Starr; Christopher M Overall; Boris Turk
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

4.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

5.  The function of cathepsins B, D, and X in atherosclerosis.

Authors:  Caroline F Zhao; David M Herrington
Journal:  Am J Cardiovasc Dis       Date:  2016-11-30

6.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

7.  The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling.

Authors:  Desmond J Tobin; Kerstin Foitzik; Thomas Reinheckel; Lars Mecklenburg; Vladimir A Botchkarev; Christoph Peters; Ralf Paus
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

8.  Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.

Authors:  W S Hou; Z Li; R E Gordon; K Chan; M J Klein; R Levy; M Keysser; G Keyszer; D Brömme
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 9.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

10.  Modulation of Cathepsin L Expression in the Coronary Arteries of Atherosclerotic Swine.

Authors:  Palanikumar Gunasekar; Mohan Satish; Parinaz Dabestani; Wanlin Jiang; Chandra Boosani; Mohammad Radwan; Devendra Agrawal; Juan Asensio
Journal:  J Surg Res       Date:  2019-08-01       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.